Ivax Pharma to Pay $14 Million to Resolve Kickback Allegations

Ivax Pharmaceuticals has agreed to pay $14 million and establish a corporate integrity agreement to resolve civil allegations that it engaged in kickback schemes with Omnicare, the nation’s largest nursing home pharmacy. The Justice Department alleges that Ivax, now a subsidiary of Teva Pharmaceutical Industries, paid $8 million in kickbacks in exchange for Omnicare’s agreement to purchase $50 million of its drugs, according to a Justice statement.
Generic Line